Oxford Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,925
| Closed | -$219K | – | 454 |
|
|
2024
Q4 | $219K | Buy |
+11,925
| New | +$219K | 0.1% | 325 |
|
|
2020
Q1 | – | Sell |
-34,476
| Closed | -$1.48M | – | 213 |
|
|
2019
Q4 | $1.48M | Sell |
34,476
-3,815
| -10% | -$163K | 0.04% | 611 |
|
|
2019
Q3 | $1.38M | Sell |
38,291
-32,111
| -46% | -$1.16M | 0.03% | 755 |
|
|
2019
Q2 | $1.88M | Buy |
70,402
+42,837
| +155% | +$1.15M | 0.04% | 662 |
|
|
2019
Q1 | $740K | Sell |
27,565
-53,091
| -66% | -$1.43M | 0.02% | 1063 |
|
|
2018
Q4 | $1.3M | Buy |
+80,656
| New | +$1.3M | 0.03% | 710 |
|
|
2014
Q3 | – | Sell |
-25,561
| Closed | -$573K | – | 665 |
|
|
2014
Q2 | $573K | Sell |
25,561
-110,250
| -81% | -$2.47M | 0.02% | 553 |
|
|
2014
Q1 | $3.3M | Buy |
+135,811
| New | +$3.3M | 0.1% | 283 |
|